Omega Therapeutics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OMGA research report →
Companywww.omegatherapeutics.com
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation.
- CEO
- Kaan Certel
- IPO
- 2021
- Employees
- 93
- HQ
- Cambridge, MA, US
Price Chart
Valuation
- Market Cap
- $7.90M
- P/E
- -0.08
- P/S
- 2.55
- P/B
- 0.13
- EV/EBITDA
- -0.73
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -2028.93%
- Op Margin
- -3240.50%
- Net Margin
- -3148.93%
- ROE
- -118.82%
- ROIC
- -51.99%
Growth & Income
- Revenue
- $3.09M · 49.25%
- Net Income
- $-97,428,000 · 5.07%
- EPS
- $-1.80 · 15.89%
- Op Income
- $-100,261,000
- FCF YoY
- 5.52%
Performance & Tape
- 52W High
- $4.44
- 52W Low
- $0.03
- 50D MA
- $0.47
- 200D MA
- $1.21
- Beta
- 1.64
- Avg Volume
- 9.59M
Get TickerSpark's AI analysis on OMGA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 24, 25 | Varsalone Jeffrey T | other | 0 |
| Dec 3, 24 | Mehrotra Ravi | other | 50,000 |
| Dec 3, 24 | Mehrotra Ravi | other | 0 |
| Nov 22, 24 | Nelson Jennifer Ann | other | 110,000 |
| Nov 22, 24 | Nelson Jennifer Ann | other | 110,000 |
| Nov 15, 24 | Certel Kaan | other | 340,000 |
| Oct 2, 24 | Rosiello Robert L. | other | 50,000 |
| Oct 2, 24 | Rosiello Robert L. | other | 0 |
| Jun 20, 24 | Szela Mary T | other | 25,000 |
| Jun 20, 24 | Boehm Rainer J. | other | 25,000 |
Our OMGA Coverage
We haven't published any research on OMGA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate OMGA Report →